NO993467L - Granules comprising clavulanate and one or more excipients - Google Patents

Granules comprising clavulanate and one or more excipients

Info

Publication number
NO993467L
NO993467L NO993467A NO993467A NO993467L NO 993467 L NO993467 L NO 993467L NO 993467 A NO993467 A NO 993467A NO 993467 A NO993467 A NO 993467A NO 993467 L NO993467 L NO 993467L
Authority
NO
Norway
Prior art keywords
clavulanate
granules
excipients
making
pharmaceutical formulations
Prior art date
Application number
NO993467A
Other languages
Norwegian (no)
Other versions
NO993467D0 (en
Inventor
Jan Willem Groenendaal
Original Assignee
Gist Brocades Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades Bv filed Critical Gist Brocades Bv
Publication of NO993467D0 publication Critical patent/NO993467D0/en
Publication of NO993467L publication Critical patent/NO993467L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Granuler av klavulanatinneholdende inerte eksipienter for farmasøytiske formuleringer har blitt tilveiebrakt. En fremgangsmåte for å fremstille de samme ved anvendelse av en sikteanordning fortrinnsvis ved anvendelse av et luftjetsystem har også blitt beskrevet.Granules of clavulanate-containing inert excipients for pharmaceutical formulations have been provided. A method of making the same using a sieving device preferably using an air jet system has also been described.

NO993467A 1997-11-17 1999-07-14 Granules comprising clavulanate and one or more excipients NO993467L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97203576 1997-11-17
PCT/EP1998/007225 WO1999025343A1 (en) 1997-11-17 1998-11-09 Granules comprising clavulanate and one or more excipients

Publications (2)

Publication Number Publication Date
NO993467D0 NO993467D0 (en) 1999-07-14
NO993467L true NO993467L (en) 1999-07-14

Family

ID=8228930

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993467A NO993467L (en) 1997-11-17 1999-07-14 Granules comprising clavulanate and one or more excipients

Country Status (13)

Country Link
EP (1) EP0973520A1 (en)
JP (1) JP2001516365A (en)
CN (1) CN1242705A (en)
AU (1) AU1337999A (en)
BR (1) BR9806280A (en)
CA (1) CA2272402A1 (en)
CO (1) CO4980893A1 (en)
JO (1) JO2082B1 (en)
NO (1) NO993467L (en)
PL (1) PL334517A1 (en)
TR (1) TR199901584T1 (en)
WO (1) WO1999025343A1 (en)
ZA (1) ZA9810499B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
EP1330236A2 (en) 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
GB0031267D0 (en) * 2000-12-21 2001-01-31 Smithkline Beecham Plc Novel compositions
AT412344B (en) * 2001-04-12 2005-01-25 Sandoz Ag Pharmaceutical composition useful for reducing rapid degradation of the active ingredient comprises clavulanate, in the form of granulated and hydrophobised particles, and an active ingredient
AT413983B (en) * 2001-04-12 2006-08-15 Sandoz Ag Pharmaceutical composition useful for reducing rapid degradation of the active ingredient comprises clavulanate, in the form of granulated and hydrophobised particles, and an active ingredient
AU2004234176B2 (en) * 2003-05-02 2010-05-13 Globopharm Pharmazeutische Produktions- Und Handelsgesellschaft M.B.H. Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts
US8293272B2 (en) * 2003-05-02 2012-10-23 Globopharm Pharmazeutische Produktions-Und Handelsgesellschaft M.B.H. Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts
FI20080352A0 (en) * 2008-05-09 2008-05-09 Atacama Labs Oy Process for preparing a tablet with high drug content
US8951562B2 (en) 2006-11-10 2015-02-10 Atacama Labs Oy Method and apparatus or dry granulation
FI20080351A0 (en) * 2008-05-09 2008-05-09 Atacama Labs Oy Process for preparing a tablet with low drug content
FI20080346A0 (en) * 2008-05-09 2008-05-09 Atacama Labs Oy Process for making a tablet containing additives
FI20080353A0 (en) * 2008-05-09 2008-05-09 Atacama Labs Oy Process for preparing a tablet with extra high drug content
FI20070521A7 (en) 2006-11-10 2008-05-11 Atacama Labs Oy Granules, tablets and granulation method
FI20080355A0 (en) * 2008-05-09 2008-05-09 Atacama Labs Oy Process for making tablets containing metformin
CA2723409C (en) 2008-05-09 2016-11-08 Atacama Labs Oy Method and apparatus for dry granulation
CN104582692A (en) * 2012-08-28 2015-04-29 中化帝斯曼制药有限公司荷兰公司 Composition comprising an antibiotic and a beta-lactamase inhibitor, wherein at| least one of them is in the form of mini-tablets
JP2014062064A (en) * 2012-09-21 2014-04-10 Ohara Yakuhin Kogyo Kk Method of producing tablets containing valsartan
JP6141472B2 (en) * 2016-03-02 2017-06-07 大原薬品工業株式会社 Method for producing valsartan-containing tablets
KR20250026366A (en) * 2017-07-05 2025-02-25 노파르티스 아게 Novel pharmaceutical composition
CN110051637A (en) * 2019-05-21 2019-07-26 葵花药业集团北京药物研究院有限公司 Amoxicillin and clavulanate potassium preparation and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2251250C3 (en) * 1972-10-19 1981-06-25 Hoechst Ag, 6230 Frankfurt Process for the production of high-dose antibiotic tablets
NZ187013A (en) * 1977-04-27 1985-04-30 Beecham Group Ltd 9-amino-9-deoxy-clavulanic acid derivatives and pharmaceutical compositions
NZ189022A (en) * 1977-12-08 1981-11-19 Beecham Group Ltd Pharmaceutically acceptable particles of clavulanates dispersed in a polymeric binder
DE3887179T2 (en) * 1987-03-02 1994-06-16 Brocades Pharma Bv Pharmaceutical composition, pharmaceutical granules and process for their preparation.
IL109770A0 (en) * 1993-05-29 1994-11-28 Smithkline Beecham Corp Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby

Also Published As

Publication number Publication date
AU1337999A (en) 1999-06-07
ZA9810499B (en) 1999-05-24
TR199901584T1 (en) 2000-01-21
CO4980893A1 (en) 2000-11-27
PL334517A1 (en) 2000-02-28
WO1999025343A1 (en) 1999-05-27
JP2001516365A (en) 2001-09-25
JO2082B1 (en) 2000-05-21
EP0973520A1 (en) 2000-01-26
NO993467D0 (en) 1999-07-14
BR9806280A (en) 2000-02-15
CN1242705A (en) 2000-01-26
CA2272402A1 (en) 1999-05-27

Similar Documents

Publication Publication Date Title
NO993467L (en) Granules comprising clavulanate and one or more excipients
AU8756798A (en) Fabrication system, method and apparatus for microelectromechanical devices
EP0893816A3 (en) Corpuscular beam apparatus
BR7603560Y1 (en) video projection apparatus.
AU7850298A (en) Monochromatic R,G,B laser light source display system and method
AU5273298A (en) Laser plasma x-ray source, semiconductor lithography apparatus using the same and a method thereof
AU5753596A (en) Silicone mask for cryosurgery
AU6397694A (en) Smoke evacuator for smoke generating devices
AU7552498A (en) Optical device, method of cleaning the same, projection aligner, and method of producing the same
AU5440498A (en) Laser apparatus having improved via processing rate
AU4786996A (en) Solid-state laser system for coloured image-projection
AUPO806497A0 (en) Image creation method and apparatus (IJ30)
AU7617596A (en) Method and device for fighting fires from the air
AU3351097A (en) Medical laser guidance apparatus
NO982738D0 (en) Invention and apparatus for microgranules containing diltiazem as active principle for sustained release
AUPO803797A0 (en) Image creation method and apparatus (IJ27)
AUPO850297A0 (en) Image processing method and apparatus (art48)
AUPO804997A0 (en) Image creation method and apparatus (IJ12)
AU2104797A (en) Passive fire fighting apparatus
DE69401030D1 (en) Aerosol formulation containing fusafungin
NO951271D0 (en) Pressure Amplifier (B)
AUPO803697A0 (en) Image creation method and apparatus (IJ13)
ITTO930477A1 (en) PROCEDURE FOR THE CREATION OF DIAPHRAGMS, BASES AND MONOLITHIC SQUARES AND RELATED EQUIPMENT.
AU8776398A (en) Optical amplifier apparatus
AU8455298A (en) Medical laser guidance apparatus

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application